Back to Journals » ClinicoEconomics and Outcomes Research » Volume 3 » default

ClinicoEconomics and Outcomes Research


Archive: Volume 3, 2011

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines

Colombo GL, Colangeli V, Di Biagio A, Di Matteo S, Viscoli C, Viale P

ClinicoEconomics and Outcomes Research 2011, 3:197-205

Published Date: 31 October 2011

Corrigendum

Zoellner Y, Balp MM, Gili Marco A

ClinicoEconomics and Outcomes Research 2011, 3:187-188

Published Date: 6 September 2011

Role of centralized review processes for making reimbursement decisions on new health technologies in Europe

Stafinski T, Menon D, Davis C, McCabe C

ClinicoEconomics and Outcomes Research 2011, 3:117-186

Published Date: 30 August 2011

The role of galenic innovation in improving treatment compliance and persistence: three case studies

Zoellner Y, Balp MM, Gili Marco A

ClinicoEconomics and Outcomes Research 2011, 3:109-116

Published Date: 4 August 2011

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy

Peng X, Ascher-Svanum H, Faries DE, Stauffer VL, Kollack-Walker S, Kinon BJ, Kane JM

ClinicoEconomics and Outcomes Research 2011, 3:79-87

Published Date: 20 April 2011

The economic burden of TNFα inhibitors and other biologic treatments in Norway

Jan Norum, Wenche Koldingsnes, Torfinn Aanes, et al

ClinicoEconomics and Outcomes Research 2011, 3:73-78

Published Date: 21 March 2011

Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A

Giorgio L Colombo, Sergio Di Matteo, Maria Elisa Mancuso, et al

ClinicoEconomics and Outcomes Research 2011, 3:55-61

Published Date: 14 March 2011

Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients

Luca Degli Esposti, Stefania Saragoni, Silvia Benemei, et al

ClinicoEconomics and Outcomes Research 2011, 3:47-54

Published Date: 7 March 2011

A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

Giorgio L Colombo, Giovanni B Gaeta, Mauro Viganò, et al

ClinicoEconomics and Outcomes Research 2011, 3:37-46

Published Date: 15 February 2011

Biosimilar medicines and cost-effectiveness

Steven Simoens

ClinicoEconomics and Outcomes Research 2011, 3:29-36

Published Date: 10 February 2011

The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease

Sevket Ozkaya, Serhat Findik, Atilla Guven Atici

ClinicoEconomics and Outcomes Research 2011, 3:15-18

Published Date: 17 January 2011

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

Xiaomei Peng, Haya Ascher-Svanum, Douglas Faries et al

ClinicoEconomics and Outcomes Research 2011, 3:9-14

Published Date: 11 January 2011

The cost-effectiveness of venous-converted acid-base and blood gas status in pulmonary medical departments

Lars Oddershede, Sabrina Storgaard Petersen, Asgerd Krogh Kristensen, et al

ClinicoEconomics and Outcomes Research 2011, 3:1-7

Published Date: 16 December 2010